Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating Investment IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxRevenueShares OutstandingShares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Metlife (MET) EBITDA (2016 - 2026)

Metlife's EBITDA history spans 18 years, with the latest figure at $42.0 million for Q1 2026.

  • Quarterly EBITDA fell 98.58% to $42.0 million in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $10.3 billion through Mar 2026, down 22.0% year-over-year, with the annual reading at $22.6 billion for FY2025, 6.05% up from the prior year.
  • EBITDA came in at $42.0 million for Q1 2026, down from $5.9 billion in the prior quarter.
  • In the past five years, EBITDA ranged from a high of $5.9 billion in Q4 2025 to a low of -$7.2 billion in Q2 2022.
  • The 5-year median for EBITDA is $1.1 billion (2025), against an average of $978.4 million.
  • Year-over-year, EBITDA crashed 334.7% in 2022 and then soared 10327.27% in 2025.
  • Metlife's EBITDA stood at $4.5 billion in 2022, then increased by 20.21% to $5.4 billion in 2023, then rose by 0.73% to $5.4 billion in 2024, then grew by 9.6% to $5.9 billion in 2025, then crashed by 99.29% to $42.0 million in 2026.
  • Per Business Quant, the three most recent readings for MET's EBITDA are $42.0 million (Q1 2026), $5.9 billion (Q4 2025), and $3.2 billion (Q3 2025).